425 related articles for article (PubMed ID: 33818412)
21. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY.
Ferm S; Fisher C; Pakala T; Tong M; Shah D; Schwarzbaum D; Cooley V; Hussain S; Kim SH
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2378-2379.e1. PubMed ID: 32497637
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
Zhang J; Garrett S; Sun J
Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician.
Chiappini E; Licari A; Motisi MA; Manti S; Marseglia GL; Galli L; Lionetti P
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):92-95. PubMed ID: 33236437
[TBL] [Abstract][Full Text] [Related]
25. Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system.
Cuicchi D; Lazzarotto T; Poggioli G
Int J Colorectal Dis; 2021 Mar; 36(3):437-444. PubMed ID: 33057894
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal Involvement in SARS-CoV-2 Infection.
Chen TH; Hsu MT; Lee MY; Chou CK
Viruses; 2022 May; 14(6):. PubMed ID: 35746659
[TBL] [Abstract][Full Text] [Related]
27. Intestinal viral infections of nSARS-CoV2 in the Indian community: Risk of virus spread in India.
Maan HS; Chaurasia D; Kapoor G; Dave L; Siddiqui A; Pal S; Singh HO; Biswas D; Chowdhary R
J Med Virol; 2022 Apr; 94(4):1315-1329. PubMed ID: 34825708
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.
Mohamed DZ; Ghoneim ME; Abu-Risha SE; Abdelsalam RA; Farag MA
World J Gastroenterol; 2021 Jul; 27(28):4504-4535. PubMed ID: 34366621
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.
Zhang Y; Cen M; Hu M; Du L; Hu W; Kim JJ; Dai N
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00343. PubMed ID: 33835096
[TBL] [Abstract][Full Text] [Related]
30. Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology.
Rohani P; Ahmadi Badi S; Moshiri A; Siadat SD
Gastroenterol Hepatol Bed Bench; 2020; 13(4):351-354. PubMed ID: 33244377
[TBL] [Abstract][Full Text] [Related]
31. [Gastrointestinal and hepatic manifestations of COVID-19 in children].
Villanueva Ch M; Faundez H R; Godoy M
Rev Chil Pediatr; 2020 Aug; 91(4):623-630. PubMed ID: 33399743
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
33. Direct COVID-19 infection of enterocytes: The role of hypochlorhydria.
Dibner JJ
Am J Infect Control; 2021 Mar; 49(3):385-386. PubMed ID: 32791258
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.
Maghool F; Valiani A; Safari T; Emami MH; Mohammadzadeh S
Scand J Immunol; 2021 Apr; 93(4):e12999. PubMed ID: 33190306
[TBL] [Abstract][Full Text] [Related]
36. COVID-19-associated diarrhea.
Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
[TBL] [Abstract][Full Text] [Related]
37. Coronavirus disease-2019 and the intestinal tract: An overview.
Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
[TBL] [Abstract][Full Text] [Related]
38. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
Bao Z; Wang LJ; He K; Lin X; Yu T; Li J; Gong J; Xiang G
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):527-540. PubMed ID: 33506945
[TBL] [Abstract][Full Text] [Related]
39. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings.
Sahu T; Mehta A; Ratre YK; Jaiswal A; Vishvakarma NK; Bhaskar LVKS; Verma HK
World J Gastroenterol; 2021 Feb; 27(6):449-469. PubMed ID: 33642821
[TBL] [Abstract][Full Text] [Related]
40. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2.
Guo M; Tao W; Flavell RA; Zhu S
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):269-283. PubMed ID: 33589829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
